Therapeutic Potential of BMP7 in the Treatment of Osteoporosis Caused by the Interaction between Inflammation and Corticosteroids in Inflammatory Bowel Disease

Therapeutic Potential of BMP7 in the Treatment of Osteoporosis Caused by the Interaction between Inflammation and Corticosteroids in Inflammatory Bowel Disease

Individuals with inflammatory bowel disease (IBD) have an increased risk of bone impairment, which is a process controlled by the RANKL/RANK/OPG system, mostly due to chronic inflammation and corticosteroid treatment. Bone morphogenic protein 7 (BMP7) has a complex role in maintaining inflammation a...

Full description

Bibliographic Details
Main Authors:	Ivana Smoljan, Dijana Detel, Suncica Buljevic, Igor Erjavec, Ivana Marić
Format:	Article
Language:	English
Published:	MDPI AG 2023-08-01
Series:	Biomedicines
Subjects:	inflammatory bowel disease bone morphogenetic proteins nuclear factor-κB ligand activator osteoprotegerin cytokines macrophage activation
Online Access:	https://www.mdpi.com/2227-9059/11/8/2161

Similar Items

An insight in to Paget′s disease of bone
by: Robin Sabharwal, et al.
Published: (2014-01-01)

OPG/RANKL/RANK cytokine system in renal osteodystrophy
by: Ivica Avberšek-Lužnik, et al.
Published: (2007-11-01)

A novel effect of geraniin on OPG/RANKL signaling in osteoblasts
by: Xiaochao Zhang, et al.
Published: (2018-11-01)

Effect of anatomical location (mandible vs maxilla) of dental implants on the BMP-2, BMP-7, sRANKL and OPG levels in periimplant crevicular fluid during osseointegration. A pilot study
by: Mehmet Sağlam, et al.
Published: (2019-12-01)

Osteoclastic activity was associated with the development of steroid-induced osteonecrosis of femoral head
by: Min-Cong He, et al.
Published: (2020-01-01)

Increase in receptor activator of nuclear factor κB ligand/osteoprotegerin ratio in peri-implant gingiva exposed to Porphyromonas gingivalis lipopolysaccharide
by: Takahiro Shuto, et al.
Published: (2016-03-01)

A Novel Small Molecule Which Increases Osteoprotegerin Expression and Protects Against Ovariectomy-Related Bone Loss in Rats
by: Xiaowan Han, et al.
Published: (2019-03-01)

Molecular mechanisms of BMP-induced bone formation: Cross-talk between BMP and NF-κB signaling pathways in osteoblastogenesis
by: Eijiro Jimi, et al.
Published: (2010-02-01)

The levels of osteoprotegerin, transforming growth factor-β, and some cytokines in women with coronary heart disease concurrent with severe osteoporosis
by: S Yu Tsarenok, et al.
Published: (2015-09-01)

Bone remodeling serum markers in children with systemic lupus erythematosus
by: Sheng Hao, et al.
Published: (2022-07-01)

Effects of IL-10 and glucose on expression of OPG and RANKL in human periodontal ligament fibroblasts
by: L. Zhang, et al.
Published: (2016-01-01)

Macrophage-Specific NF-κB Activation Dynamics Can Segregate Inflammatory Bowel Disease Patients
by: Stamatia Papoutsopoulou, et al.
Published: (2019-09-01)

Probiotic <i>Propionibacterium freudenreichii</i> MJ2 Enhances Osteoblast Differentiation and Mineralization by Increasing the OPG/RANKL Ratio
by: Jiah Yeom, et al.
Published: (2021-03-01)

Circulating levels of osteoprotegerin and sRANKL and the effect of methotrexate in patients with rheumatoid arthritis
by: Aadhaar Dhooria, et al.
Published: (2018-01-01)

A targeted approach for evaluating preclinical activity of botanical extracts for support of bone health
by: Yumei Lin, et al.
Published: (2014-01-01)

Application of BMP-2 and its gene delivery vehicles in dentistry
by: Valeriya Sergeevna Kuznetsova, et al.
Published: (2024-06-01)

Protection against Osteoporosis by Fermented Mulberry Vinegar Supplementation via Inhibiting Osteoclastic Activity in Ovariectomized Rats and Osteoclastic Cells
by: Eun Jung Yim, et al.
Published: (2022-05-01)

Polylactic/polyglycolic acid copolymer is a good carrier for BMP-2 on bone regeneration?
by: Alexandre Ladeira Veloso dos Anjos, et al.
Published: (2017-05-01)

Expressions of Osteoprotegerin and Receptor Activator of Nuclear Factor Kappa-B Ligand in Alveolar Bone Socket under Low Plasma Estrogen Level Condition
by: Agung Krismariono, et al.
Published: (2017-10-01)

The role of genetic and metabolic disorders in osteoporosis
by: L. V. Vasilyeva, et al.
Published: (2021-03-01)

Pangasius djambal gelatin increases osteoprotegerin, decreases RANK and RANKL after tooth extraction in vivo
by: Fredy Mardiyantoro, et al.
Published: (2023-12-01)

Association of RANKL and EGFR gene expression with bone metastases in patients with metastatic non-small cell lung cancer
by: Anita J.W.M. Brouns, et al.
Published: (2023-05-01)

Clinical Significance of Erythroferrone and Bone Morphogenetic Protein-6 in Patients with Anemia in the Course of Inflammatory Bowel Disease
by: Małgorzata Woźniak, et al.
Published: (2023-09-01)

Effect of sumac extract on serum oxidative status, RANKL/OPG system and alveolar bone loss in experimental periodontitis in rats
by: Mehmet SAĞLAM, et al.
Published: (2015-02-01)

Dysregulation of the RANKL/RANK/OPG axis in thalassemia intermedia patients
by: Mahmoud A. Alfaqih, et al.
Published: (2018-07-01)

Arterial stiffness, vascular calcification and osteoporosis — common mechanisms of interaction (literature review)
by: O.I. Nishkumay, et al.
Published: (2022-06-01)

The effect of liposomal composition with encapsulated potassium orotate on the macrophage link of immunity in the treatment of wounds
by: V. V. Mosyagin, et al.
Published: (2024-09-01)

Chensinin-1b Alleviates DSS-Induced Inflammatory Bowel Disease by Inducing Macrophage Switching from the M1 to the M2 Phenotype
by: Yue Sun, et al.
Published: (2024-02-01)

RANK/RANKL/OPG LIGAND-RECEPTOR SYSTEM AND ITS ROLE IN PRIMARY BONE NEOPLASMS (LITERATURE ANALYSIS AND OWN DATA)
by: E. S. Gershtein, et al.
Published: (2015-12-01)

Zoledronate Bound to Ceramics Increases Ectopic Bone Volume Induced by rhBMP6 Delivered in Autologous Blood Coagulum in Rats
by: Nikola Stokovic, et al.
Published: (2021-10-01)

Interleukin-18 serum levels in inflammatory bowel diseases: correlation with disease activity and inflammatory markers
by: SL Haas, et al.
Published: (2009-03-01)

Role of Melatonin in Down-regulation of Receptor Activator of Nuclear Factor kappa-B Ligand : Osteoprotegerin Ratio in Rat - Bone-Marrow Mesenchymal Stem Cells
by: Adya Pramusita, et al.
Published: (2018-10-01)

The tooth eruption and its abnormalities - A narrative review
by: K V Sai Charan, et al.
Published: (2022-01-01)

The Deep-Sea Natural Products, Biogenic Polyphosphate (Bio-PolyP) and Biogenic Silica (Bio-Silica), as Biomimetic Scaffolds for Bone Tissue Engineering: Fabrication of a Morphogenetically-Active Polymer
by: Florian Draenert, et al.
Published: (2013-03-01)

Opportunities for management of macrophage phenotype reprogramming
by: V. N. Sakharov, et al.
Published: (2022-12-01)

Apatite-Polymer Composite Particles for Controlled Delivery of BMP-2
by: Yong, Tseh-Hwan, et al.
Published: (2003)

Evaluation of Receptor Activator of Nuclear Factor Kappa-B Ligand and Osteoprotegerin Levels in Patients with Type 2 Diabetes Mellitus Treated with Oral Anti-diabetics (Sulfonylurea and Metformin) or Insulin: Bone Tissue Perspective
by: Alper Gümüş, et al.
Published: (2019-03-01)

Duchenne muscular dystrophy: RANK/RANKL/OPG (receptor activator of nuclear factor-kB/RANK ligand/osteoprotegerin) system and glucocorticoids
by: Salvador Atilano-Miguel, et al.
Published: (2022-01-01)

Association between pathogenesis of atherosclerosis and osteoporosis
by: Andrey Verbovoy, et al.
Published: (2016-12-01)

Proinflammatory cytokines in irritable bowel syndrome: a comparison with inflammatory bowel disease
by: Antigony Mitselou, et al.
Published: (2020-01-01)